Smith & Wesson Brands (SWBI) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
22 Jan, 2026Executive summary
Q1 FY25 net sales were $88.3 million, down 22.7% year-over-year, reflecting softer-than-expected firearms demand, pronounced summer seasonality, and inflationary pressures, but demand began rebounding as the fall season approached.
Gross margin improved to 27.4% from 26.6% in the prior year, aided by favorable fixed-cost absorption, price increases, and lower relocation costs.
Net loss was $2.1 million ($0.05 per share) compared to net income of $3.1 million ($0.07 per share) in the prior year quarter; non-GAAP net loss was $1.0 million ($0.02 per share).
New product launches, especially the Bodyguard 2.0 and 1854 lever-action rifle, drove strong performance, with new products accounting for over 41% of sales.
870,669 shares were repurchased for $12.9 million during the quarter; a new $50 million repurchase authorization was approved for the next year.
Financial highlights
Handgun sales fell 38.1% to $53.3 million; long gun sales rose 31.6% to $24.7 million; other products/services up 10.5% to $5.9 million.
Operating loss was $1.9 million (-2.1% margin) versus $4.3 million operating income (3.8% margin) last year.
Cash used in operations was $30.8 million, primarily due to a $30 million inventory build; free cash flow was negative $35.5 million.
Ended Q1 with $35.5 million in cash and $70 million in borrowings on the revolving credit line at a 7.19% average rate.
Operating expenses were $26.1 million, flat year-over-year, with increased costs offset by the absence of prior year impairment.
Outlook and guidance
Q2 sales expected to grow significantly over Q1, with full-year revenue projected to rise mid- to high-single digits over FY24.
Gross margins are expected to improve in Q2 but not reach 30% until the second half; targeting low 30s for the full year.
Operating expenses in Q2 projected to be about 15% higher than Q1, with an effective tax rate of 25%.
Inventory levels expected to rise slightly in Q2 before declining for the remainder of the fiscal year.
Management believes existing capital resources and credit facilities are adequate for at least the next 12 months.
Latest events from Smith & Wesson Brands
- Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025 - Q2 sales dipped 3.9% but cash flow and new product momentum support a strong Q3 outlook.SWBI
Q2 20267 Dec 2025 - Director elections, say-on-pay, and a human rights proposal headline a governance-focused agenda.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and performance.SWBI
Proxy Filing1 Dec 2025